© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who would prefer monthly injections to daily pills.
A new long-acting injectables HIV drug shows promise in monkey study.
MK-8507, a long-acting NNRTI, will be tested in a weekly regimen with islatravir.
The HIV protease inhibitor combination did not speed recovery or reduce the risk of death in a large study.
The effect is greater for women, and it could have a detrimental effect on pregnancy outcomes at the population level.
Antiretroviral therapy helped people with the virus add years to their lives, but now scientists must address other issues of longevity.
The latest revision recognizes the importance of treatment as prevention.
The Miami program IDEA Exchange provides secure locations to store meds.
HIV and psoriasis
Science = life
The effects of probiotics on HIV treatment
The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.
Final results from the PARTNER 2 study of gay and bi men confirm that undetectable equals untransmittable.
What happens if individuals with HIV skip or stop antiretroviral therapy?
Why HIV testing is key
If you test positive for HIV, start therapy ASAP.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
